Wolverine Trading, LLC Takeda Pharmaceutical CO LTD Put Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $272,619 - $339,479	-20,700 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $55,420 - $58,684	-3,400 Reduced 14.11%	20,700 $338,000
Q2 2021 Aug 06, 2021	SELL	$16.55 - $18.64 $425,335 - $479,048	-25,700 Reduced 51.61%	24,100 $406,000
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $277,386 - $330,340	16,600 Added 50.0%	49,800 $914,000
Q4 2020 Feb 12, 2021	BUY	$15.39 - $18.97 $89,262 - $110,026	5,800 Added 21.17%	33,200 $604,000
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $68,400 - $76,760	-4,000 Reduced 12.74%	27,400 $497,000
Q2 2020 Aug 13, 2020	SELL	$14.59 - $19.5 $163,408 - $218,400	-11,200 Reduced 26.29%	31,400 $569,000
Q1 2020 May 11, 2020	BUY	$13.02 - $20.31 $554,652 - $865,206	42,600 New	42,600 $666,000
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $539,410 - $600,866	-33,400 Closed	0 $0
Q2 2019 Aug 20, 2019	BUY	$16.58 - $20.49 $225,487 - $278,664	13,600 Added 68.69%	33,400 $591,000
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $330,660 - $426,096	19,800 New	19,800 $403,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.